Lakewood-Amedex Biotherapeutics Inc. Stock-Based Compensation
Lakewood-Amedex Biotherapeutics Inc. (LABT) reported Stock-Based Compensation of $107.42 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-09-18
- Lakewood-Amedex Biotherapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $61.24K, a 25.18% increase year-over-year.
- Lakewood-Amedex Biotherapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $46.18K, a 14.12% decline year-over-year.
- Lakewood-Amedex Biotherapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $48.92K.
- Lakewood-Amedex Biotherapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $53.77K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $61.24K derived: S-1 6 month − 10-Q 3 month · filed 2026-09-18 | $107.42K S-1 · filed 2026-09-18 | |
| 2026-03-31 | $46.18K 10-Q · filed 2026-05-22 | ||
| 2025-12-31 | $1.35M S-1 · filed 2026-09-18 | ||
| 2025-06-30 | $48.92K derived: S-1 6 month − 10-Q 3 month · filed 2026-09-18 | $102.70K S-1 · filed 2026-09-18 | |
| 2025-03-31 | $53.77K 10-Q · filed 2026-05-22 | ||
| 2024-12-31 | $269.67K S-1 · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B |